Processing

Please wait...

Settings

Settings

Goto Application

1. GB2493313 - Kissorphin peptides for use in the treatment of alzheimer's disease, creutzfeldt-jakob disease or diabetes mellitus

EP2388012Kisspeptin peptides for use in the treatment of Alzheimer's disease, Creutzfeldt-Jakob disease or diabetes mellitus
Appl.Date 20.05.2010
Appl.No 10163479 Applicant ROEHAMPTON UNIVERSITY Related Type IC5
Sole priority inside the family.
Pub.Kind A1 Pub.Lang en
Pub.Date 23.11.2011
GB2493313Kissorphin peptides for use in the treatment of alzheimer's disease, creutzfeldt-jakob disease or diabetes mellitus
Appl.Date 19.05.2011
Appl.No 201220630 Applicant ROEHAMPTON UNIV Related Type IC6
Connected by priority field.
Pub.Kind A,D0,B Pub.Lang en
Pub.Date 02.01.2013
WO/2011/144714KISSORPHIN PEPTIDES FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE, CREUTZFELDT- JAKOB DISEASE OR DIABETES MELLITUS
Appl.Date 19.05.2011
Appl.No PCT/EP2011/058213 Applicant MILTON, Nathaniel Related Type IC1
PCT application from which the family originated.
Pub.Kind A Pub.Lang en
Pub.Date 24.11.2011